PBSV— Pharma-Bio Serv, Inc.

$11M mkt cap

Metric	FY2025	FY2024	FY2023	FY2022
REVENUES	$9.0M-5.3%	$9.5M-44.0%	$17.0M-12.5%	$19.4M
COST OF SERVICES	$6.1M-12.9%	$7.0M-41.3%	$11.9M-18.0%	$14.5M
GROSS PROFIT	$2.9M+15.7%	$2.5M-50.3%	$5.1M+3.8%	$4.9M
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES	$3.5M-6.7%	$3.8M-3.7%	$3.9M+6.5%	$3.7M
LOSS FROM OPERATIONS	-$638K+50.5%	-$1.3M-215.2%	$1.1M-4.9%	$1.2M
OTHER INCOME, NET	$543K+2.1%	$532K-6.7%	$570K+4148.6%	$13K
LOSS BEFORE INCOME TAX	-$94K+87.5%	-$755K-144.8%	$1.7M+42.0%	$1.2M
INCOME TAX EXPENSE	$6K-72.0%	$22K-94.1%	$377K+107.7%	$182K
NET LOSS	-$100K+87.1%	-$778K-159.4%	$1.3M+30.1%	$1.0M
BASIC AND DILUTED LOSS PER SHARE OF COMMON STOCK	-$0.00+88.2%	-$0.03-159.6%	$0.06	—
SHARES OUTSTANDING - BASIC	22.9M-0.1%	23.0M-0.0%	23.0M-0.1%	23.0M
SHARES OUTSTANDING - DILUTED	23.0M-0.1%	23.0M-0.1%	23.0M-0.1%	23.0M

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 12 more years of annual history and full quarterly detail on Pro.

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.